Lene Surland Knudsen

Lene Surland Knudsen

Clinical Associate Professor

Member of:

  • Internal medicine: infection medicine


Publication year:
All
1 - 10 out of 13Page size: 10
  1. 2008
  2. Published

    Interleukin-6, vascular endothelial growth factor and YKL-40 as biomarkers of inflammation in patients with rheumatoid arthritis

    Knudsen, Lene Surland, 2008

    Research output: Book/Report › Ph.D. thesis › Research

  3. 2009
  4. Published

    Changes in plasma IL-6, plasma VEGF and serum YKL-40 during Treatment with Etanercept and Methotrexate or Etanercept alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy

    Knudsen, Lene Surland, Hetland, Merete Lund, Johansen, Julia Sidenius, Skjødt, H., Peters, N. D., Colic, A., Grau, K., Nielsen, H. J., Østergaard, Mikkel, Knudsen, L. S., Hetland, M. L., Johansen, J. S., Skjødt, H., Peters, N. D., Colic, A., Grau, K., Nielsen, H. J. & Østergaard, Mikkel, 2009, In: Biomarker Insights. 4, p. 91-5 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. 2012
  6. Published

    CD4⁺ and CD8⁺ regulatory T cells (Tregs) are elevated and display an active phenotype in patients with chronic HCV mono-infection and HIV/HCV co-infection

    Hartling, Hans Jakob Stilling, Gaardbo, J. C., Ronit, A., Knudsen, Lene Surland, Ullum, H., Vainer, B., Clausen, M. R., Skogstrand, K., Gerstoft, Jan & Nielsen, Sabine Dahl, Sep 2012, In: Scandinavian Journal of Immunology. 76, 3, p. 294-305 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. 2019
  8. Published

    Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

    INSIGHT FLU-IVIG Study Group, I. F. S. G., 2019, In: The Lancet Respiratory Medicine. 7, 11, p. 951-963 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. 2020
  10. Published

    Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia (COVID STEROID) trial-Protocol and statistical analysis plan

    Petersen, M. W., Meyhoff, T. S., Helleberg, M., Kjaer, M-B. N., Granholm, A., Hjortso, C. J. S., Jensen, T. S., Moller, M. H., Hjortrup, P. B., Wetterslev, M., Vesterlund, G. K., Russell, L., Jorgensen, V. L., Tjelle, K., Benfield, T., Ulrik, C. S., Andreasen, A. S., Mohr, T., Bestle, M. H., Poulsen, L. M. & 21 others, Hitz, Mette Friberg, Hildebrandt, T., Knudsen, Lene Surland, Moller, A., Solling, C. G., Brochner, A. C., Rasmussen, B. S., Nielsen, H., Christensen, S., Strom, T., Cronhjort, M., Wahlin, R. R., Jakob, S., Cioccari, L., Venkatesh, B., Hammond, N., Jha, V., Myatra, S. N., Gluud, C., Lange, Theis & Perner, Anders, 2020, In: Acta Anaesthesiologica Scandinavica. 64, 9, p. 1365-1375 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. 2021
  12. Published

    Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: The COVID STEROID randomised, placebo-controlled trial

    Munch, M. W., Meyhoff, T. S., Helleberg, M., Kjær, M. B. N., Granholm, A., Hjortsø, C. J. S., Jensen, T. S., Møller, M. H., Hjortrup, P. B., Wetterslev, M., Vesterlund, G. K., Russell, L., Jørgensen, V. L., Kristiansen, K. T., Benfield, T., Ulrik, C. S., Andreasen, A. S., Bestle, M. H., Poulsen, L. M., Hildebrandt, T. & 52 others, Knudsen, Lene Surland, Møller, A., Sølling, C. G., Brøchner, A. C., Rasmussen, B. S., Nielsen, H., Christensen, S., Strøm, T., Cronhjort, M., Wahlin, R. R., Jakob, S. M., Cioccari, L., Venkatesh, B., Hammond, N., Jha, V., Myatra, S. N., Jensen, M. Q., Leistner, J. W., Mikkelsen, V. S., Svenningsen, J. S., Laursen, S. B., Hatley, E. V., Kristensen, C. M., Al-Alak, A., Clapp, E., Jonassen, T. B., Bjerregaard, C. L., Østerby, N. C. H., Jespersen, M. M., Abou-Kassem, D., Lassen, M. L., Zaabalawi, R., Daoud, M. M., Abdi, S., Meier, N., la Cour, K., Derby, C. B., Damlund, B. R., Laigaard, J., Andersen, L. L., Mikkelsen, J., Jensen, J. L. S., Rasmussen, A. H., Arnerlöv, E., Lykke, M., Holst-Hansen, M. Z. B., Tøstesen, B. W., Schwab, J., Madsen, E. K., Gluud, C., Lange, Theis & Perner, Anders, 2021, In: Acta Anaesthesiologica Scandinavica. 65, 10, p. 1421-1430 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. 2022
  14. Published

    Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study

    Søgaard, O. S., Reekie, J., Johansen, I. S., Nielsen, H., Benfield, T., Wiese, L., Stærke, N. B., Iversen, K., Fogh, K., Bodilsen, J., Iversen, M., Knudsen, L. S., Klastrup, V., Larsen, F. D., Andersen, S. D., Hvidt, A. K., Andreasen, S. R., Madsen, L. W., Lindvig, S. O., Øvrehus, A. & 11 others, Ostrowski, Sisse Rye, Abildgaard, C., Matthews, C., Jensen, T. O., Raben, D., Erikstrup, C., Fischer, Thea Kølsen, Tolstrup, M., Østergaard, L., Lundgren, Jens & ENFORCE Writing Group, E. W. G., 2022, In: Clinical Microbiology and Infection. 28, 4, p. 1126-1133 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    Cohort Profile:The Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 vaccines (ENFORCE)

    ENFORCE Study Group, E. S. G., 2022, In: BMJ Open. 12, 12, p. e069065

    Research output: Contribution to journal › Journal article › Research › peer-review

  16. Published

    Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

    Self, W. H., Sandkovsky, U., Reilly, C. S., Vock, D. M., Gottlieb, R. L., Mack, M., Golden, K., Dishner, E., Vekstein, A., Ko, E. R., Der, T., Franzone, J., Almasri, E., Fayed, M., Filbin, M. R., Hibbert, K. A., Rice, T. W., Casey, J. D., Hayanga, J. A., Badhwar, V. & 31 others, Leshnower, B. G., Sharifpour, M., Knowlton, K. U., Peltan, I. D., Bakowska, E., Kowalska, J., Bowdish, M. E., Sturek, J. M., Rogers, A. J., Files, D. C., Mosier, J. M., Gong, M. N., Douin, D. J., Hite, R. D., Trautner, B. W., Jain, M. K., Jensen , Jens-Ulrik Stæhr , Clausen, C. L., Hovmand, N., Pedersen, Karen Bjerg, Thorlacius-Ussing, L., Tinggaard, M., Rastoder, E., Helleberg, Marie, Gerstoft, Jan, Lindegaard, Birgitte, Pedersen, T. I., Johnsen, Stine, Wiese, L., Knudsen, Lene Surland & ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group, A. F. I. W. C. (. S. G., 2022, In: The Lancet Infectious Diseases. 22, 5, p. 622-635 14 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  17. Published

    Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections

    Staerke, N. B., Reekie, J., Nielsen, H., Benfield, T., Wiese, L., Knudsen, L. S., Iversen, M. B., Iversen, K., Fogh, K., Bodilsen, J., Juhl, M. R., Lindvig, S. O., Ovrehus, A., Madsen, L. W., Klastrup, V., Andersen, S. D., Juhl, A. K., Andreasen, S. R., Ostrowski, S. R., Erikstrup, C. & 6 others, Fischer, Thea Kølsen, Tolstrup, M., Østergaard, L., Johansen, I. S., Lundgren, Jens & Sogaard, O. S., 2022, In: Nature Communications. 13, 1, 8 p., 4466.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 Next

ID: 226894052